Assenagon Asset Management
FLGT icon

Assenagon Asset Management’s Fulgent Genetics FLGT Stock Holding History

Assenagon Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,949
Closed -$1.69M – 1410
2022
Q2 		$1.69M Buy
30,949
+3,475
+13% +$191K 0.01% 893
2022
Q1 		$1.72M Buy
27,474
+9,793
+55% +$645K ﹤0.01% 895
2021
Q4 		$1.78M Buy
17,681
+1,665
+10% +$146K 0.01% 853
2021
Q3 		$1.44M Sell
16,016
-1,669
-9% -$152K ﹤0.01% 802
2021
Q2 		$1.63M Buy
+17,685
New +$1.41M 0.01% 755

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Assenagon Asset Management's FLGT Position: Q3 2022 in Review

Assenagon Asset Management sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 30,949 shares — an estimated $1.69M sold.

Assenagon Asset Management first reported a position in FLGT in Q2 2021 and held it in 5 quarters. The position peaked at $1.78M in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Assenagon Asset Management reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 30,949 Fulgent Genetics shares in Q3 2022, an estimated $1.69M.
  • Assenagon Asset Management first reported a position in Fulgent Genetics in Q2 2021 and held it in 5 quarters.
  • Assenagon Asset Management's Fulgent Genetics position peaked at $1.78M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Assenagon Asset Management's 13F filing for Q3 2022, filed 27 Oct 2022.